ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00718601
Recruitment Status : Completed
First Posted : July 18, 2008
Last Update Posted : December 24, 2015
Sponsor:
Information provided by (Responsible Party):
Geron Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : October 2011